Intercept Pharmaceuticals, Inc.

BANK OF AMERICA CORP /DE/

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

402,359

Value ($000)

7,460

Weight

0.0%

2013 Q4 - 2023 Q3 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	7,460	0.0%	402,359	9/30/2023
2023 Q2	8/14/2023	3,273	0.0%	295,936	6/30/2023
2023 Q1	5/12/2023	4,980	0.0%	370,818	3/31/2023
2022 Q4	2/10/2023	6,528	0.0%	527,689	12/31/2022
2022 Q3	11/14/2022	6,182	0.0%	443,163	9/30/2022
2022 Q2	8/12/2022	4,551	0.0%	329,596	6/30/2022
2022 Q1	5/16/2022	6,873	0.0%	422,440	3/31/2022
2021 Q4	2/8/2022	6,174	0.0%	379,060	12/31/2021
2021 Q3	11/15/2021	3,103	0.0%	208,944	9/30/2021
2021 Q2	9/13/2021	4,741	0.0%	237,419	6/30/2021
2021 Q1	5/14/2021	5,461	0.0%	236,644	3/31/2021
2020 Q4	2/10/2021	5,071	0.0%	205,289	12/31/2020
2020 Q3	11/13/2020	8,033	0.0%	193,748	9/30/2020
2020 Q2	8/14/2020	10,723	0.0%	223,825	6/30/2020
2020 Q1	5/15/2020	10,605	0.0%	168,459	3/31/2020
2019 Q4	2/14/2020	22,040	0.0%	177,856	12/31/2019
2014 Q1	5/15/2014	21,160	0.0%	64,161	3/31/2014
2013 Q4	2/18/2014	2,356	0.0%	34,509	12/31/2013